Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

手紙: 転移因子療法後の循環中のインターフェロン

G Emödi, M Just, P Grob

    Lancet (London, England)
    |December 15, 1973
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

    ESMO open·2026
    Same author

    Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

    ESMO open·2025
    Same author

    Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

    ESMO open·2025
    Same author

    The impact of an online self-management programme for type 2 diabetes. The BEATdiabetes prospective service evaluation.

    Primary care diabetes·2025
    Same author

    Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

    ESMO open·2025
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    The US Ebola response and the future of global health leadership.

    Lancet (London, England)·2026
    Same journal

    Daniel Mason: a tale of change.

    Lancet (London, England)·2026
    Same journal

    The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

    Lancet (London, England)·2026
    Same journal

    Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

    Lancet (London, England)·2026
    Same journal

    LGBTQ+ Russians increasingly avoiding doctors.

    Lancet (London, England)·2026
    関連記事をすべて見る